AI-Optimized CLD
From Screening to Design: Can Production Cell Lines Become Programmable Platforms?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-19Jul 20, 2026
Gender Bias AI
Testing and Correcting Gender Bias in Healthcare AI
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-21Jun 24, 2026
CNS Clinical
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969
Insilico Medicine
PR-06-26-01Jun 17, 2026
Protein Engineering
Exponential Advances in Protein Engineering
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-26-PA-04Jun 8, 2026
AI in Manufacturing
Validating and Governing AI in GMP Manufacturing
Pharma's Almanac
PAO-06-26-PA-03Jun 4, 2026
AI Data Integrity
Data Integrity in the Age of AI-Assisted Manufacturing
Pharma's Almanac
PAO-06-26-PA-02Jun 3, 2026
Partnership
The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation
The Solubility Company
PR-05-26-02May 13, 2026
Appointment
Dr.Evidence Appoints David Pennington as Chief Executive Officer
Dr.Evidence
PR-04-26-07Apr 9, 2026
RWD
Accelerating and Simplifying the Use of Complex and Comprehensive Real-World Data
Seray Cicek
PointClickCare Life Sciences
PAO-02-26-CL-06Apr 9, 2026
Formulation
Quotient Sciences and Intrepid Labs form Strategic Partnership to Accelerate AI-guided Formulation Development
Quotient Sciences
PR-04-26-05Apr 1, 2026
Early-Phase Trials
Innovations in Early-Phase Clinical Trials: Pioneering the Future of Medicine
Craig Boyle. M.D.
Trialmed
PAO-02-26-CL-05Mar 2, 2026
Recruitment
Transforming Effective Patient Recruitment within the Changing Healthcare Landscape
Altair Silva; Sarah Rudolph; Zhe Rachel Angerer
PPD clinical research business of Thermo Fisher Scientific
PAO-01-26-CL-02Jan 22, 2026
Digital Formulation
Digital and In Silico Transformation in Biologics Formulation
Tim Menzen, Ph.D.; Andrea Arsiccio, Ph.D.,
Coriolis Pharma
PAO-12-25-CL-02Dec 9, 2025
CDMO Excellence
Delivering CDMO Excellence, Quality, and Value through Dedication
Adriana Kiędzierska–Mencfeld, Ph.D.
Rezon Bio
PAO-12-25-CL-01Dec 2, 2025
Chinese Biotechs
Rising Biotech Innovation Outside the U.S.: China Leading the Surge
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-25-NI-05Nov 17, 2025
End-to-End GenAI
The Rise of Truly Virtual Pharma: Generative AI Ecosystems for End-to-End Drug Design
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-25-NI-03Nov 12, 2025
OSD
Technologies Enabling Personalized and Patient-Specific Oral Solid Dosage Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-11-25-NI-02Nov 11, 2025
Technology
What do you consider to be the most important new tools or technology platforms currently being developed?
Pharma's Almanac
PAO-10-25-RT-02Nov 3, 2025
Biological Design
Foundational Models in Biological Design, Part 3: Translational and Regulatory Outlook
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-25-NI-06COct 20, 2025
Biological Design
Foundational Models in Biological Design, Part 2: Designing for Manufacturability
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-25-NI-06BOct 20, 2025